BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33790888)

  • 1. C-Reactive Protein Enhances IgG-Mediated Cellular Destruction Through IgG-Fc Receptors
    Temming AR; Tammes Buirs M; Bentlage AEH; Treffers LW; Feringa H; de Taeye SW; Kuijpers TW; Nagelkerke SQ; Brasser G; Mok JY; van Esch WJE; van den Berg TK; Rispens T; van der Schoot CE; Vidarsson G
    Front Immunol; 2021; 12():594773. PubMed ID: 33790888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
    Treffers LW; van Houdt M; Bruggeman CW; Heineke MH; Zhao XW; van der Heijden J; Nagelkerke SQ; Verkuijlen PJJH; Geissler J; Lissenberg-Thunnissen S; Valerius T; Peipp M; Franke K; van Bruggen R; Kuijpers TW; van Egmond M; Vidarsson G; Matlung HL; van den Berg TK
    Front Immunol; 2018; 9():3124. PubMed ID: 30761158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
    Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
    Front Immunol; 2019; 10():704. PubMed ID: 31031746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcgammaRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis.
    Bodman-Smith KB; Gregory RE; Harrison PT; Raynes JG
    J Leukoc Biol; 2004 Jun; 75(6):1029-35. PubMed ID: 15075346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
    Brandsma AM; Ten Broeke T; Nederend M; Meulenbroek LA; van Tetering G; Meyer S; Jansen JH; Beltrán Buitrago MA; Nagelkerke SQ; Németh I; Ubink R; Rouwendal G; Lohse S; Valerius T; Leusen JH; Boross P
    Cancer Immunol Res; 2015 Dec; 3(12):1316-24. PubMed ID: 26407589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI.
    Crowell RE; Du Clos TW; Montoya G; Heaphy E; Mold C
    J Immunol; 1991 Nov; 147(10):3445-51. PubMed ID: 1834740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.
    Li B; Xu L; Tao F; Xie K; Wu Z; Li Y; Li J; Chen K; Pi C; Mendelsohn A; Larrick JW; Gu H; Fang J
    Oncotarget; 2017 Jun; 8(24):39356-39366. PubMed ID: 28454118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotypes of FcγRIIa and FcγRIIIb polymorphic variants influence IgG-mediated responses in neutrophils.
    van der Heijden J; Nagelkerke S; Zhao X; Geissler J; Rispens T; van den Berg TK; Kuijpers TW
    J Immunol; 2014 Mar; 192(6):2715-21. PubMed ID: 24554771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.
    Sonneveld ME; van der Schoot CE; Vidarsson G
    J Clin Immunol; 2016 May; 36 Suppl 1():76-81. PubMed ID: 26961360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies.
    Borghi S; Bournazos S; Thulin NK; Li C; Gajewski A; Sherwood RW; Zhang S; Harris E; Jagannathan P; Wang LX; Ravetch JV; Wang TT
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12943-12951. PubMed ID: 32461366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptor-mediated immunity against Bordetella pertussis.
    Rodriguez ME; Hellwig SM; Hozbor DF; Leusen J; van der Pol WL; van de Winkel JG
    J Immunol; 2001 Dec; 167(11):6545-51. PubMed ID: 11714823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells.
    Kilpatrick JM; Volanakis JE
    J Immunol; 1985 May; 134(5):3364-70. PubMed ID: 3156933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
    Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
    J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgGA: a "cross-isotype" engineered human Fc antibody domain that displays both IgG-like and IgA-like effector functions.
    Kelton W; Mehta N; Charab W; Lee J; Lee CH; Kojima T; Kang TH; Georgiou G
    Chem Biol; 2014 Dec; 21(12):1603-9. PubMed ID: 25500223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
    Mullarkey CE; Bailey MJ; Golubeva DA; Tan GS; Nachbagauer R; He W; Novakowski KE; Bowdish DM; Miller MS; Palese P
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia.
    Kapur R; Heitink-Pollé KM; Porcelijn L; Bentlage AE; Bruin MC; Visser R; Roos D; Schasfoort RB; de Haas M; van der Schoot CE; Vidarsson G
    Blood; 2015 Mar; 125(11):1793-802. PubMed ID: 25548320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregated C-reactive protein binds to human polymorphonuclear leukocytes and potentiates Fc receptor-mediated chemiluminescence.
    Zeller JM; Landay AL; Lint TF; Gewurz H
    J Lab Clin Med; 1986 Dec; 108(6):567-76. PubMed ID: 2946790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Fcγ receptors in HER2-targeted breast cancer therapy.
    Musolino A; Gradishar WJ; Rugo HS; Nordstrom JL; Rock EP; Arnaldez F; Pegram MD
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34992090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.